DSC1
gene geneOn this page
Also known as CDHF1
Summary
DSC1 (desmocollin 1, HGNC:3035) is a protein-coding gene on chromosome 18q12.1, encoding Desmocollin-1 (Q08554). A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion.
The protein encoded by this gene is a calcium-dependent glycoprotein that is a member of the desmocollin subfamily of the cadherin superfamily. These desmosomal family members, along with the desmogleins, are found primarily in epithelial cells where they constitute the adhesive proteins of the desmosome cell-cell junction and are required for cell adhesion and desmosome formation. A subtype of IgA pemphigus, a life-threatening autoimmune disease, is characterized by the presence of autoantibodies that target the encoded protein. The desmosomal family members are arranged in two clusters on chromosome 18. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature protein.
Source: NCBI Gene 1823 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 126 total — 2 pathogenic
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_024421
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3035 |
| Approved symbol | DSC1 |
| Name | desmocollin 1 |
| Location | 18q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CDHF1 |
| Ensembl gene | ENSG00000134765 |
| Ensembl biotype | protein_coding |
| OMIM | 125643 |
| Entrez | 1823 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000257197, ENST00000257198
RefSeq mRNA: 2 — MANE Select: NM_024421
NM_004948, NM_024421
CCDS: CCDS11894, CCDS11895
Canonical transcript exons
ENST00000257198 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000523707 | 31140042 | 31140301 |
| ENSE00000667544 | 31131594 | 31131842 |
| ENSE00000667548 | 31132568 | 31132689 |
| ENSE00000667549 | 31133891 | 31134130 |
| ENSE00000667554 | 31141999 | 31142184 |
| ENSE00000667555 | 31143657 | 31143791 |
| ENSE00000667556 | 31145611 | 31145777 |
| ENSE00000667562 | 31159445 | 31159529 |
| ENSE00000796889 | 31157371 | 31157573 |
| ENSE00000796890 | 31156043 | 31156162 |
| ENSE00000796891 | 31154774 | 31154929 |
| ENSE00000796892 | 31148498 | 31148642 |
| ENSE00000796897 | 31139748 | 31139890 |
| ENSE00000796898 | 31134572 | 31134784 |
| ENSE00003555152 | 31129236 | 31130711 |
| ENSE00003902555 | 31162532 | 31162856 |
Expression profiles
Bgee: expression breadth ubiquitous, 102 present calls, max score 99.63.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.1944 / max 1459.8138, expressed in 80 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 171561 | 1.3294 | 45 |
| 171563 | 0.5507 | 49 |
| 171562 | 0.3143 | 16 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper leg skin | UBERON:0004262 | 99.63 | gold quality |
| skin of hip | UBERON:0001554 | 99.51 | gold quality |
| upper arm skin | UBERON:0004263 | 99.38 | gold quality |
| penis | UBERON:0000989 | 99.19 | gold quality |
| nipple | UBERON:0002030 | 98.87 | gold quality |
| mammalian vulva | UBERON:0000997 | 98.44 | gold quality |
| zone of skin | UBERON:0000014 | 96.70 | gold quality |
| skin of leg | UBERON:0001511 | 96.44 | gold quality |
| skin of abdomen | UBERON:0001416 | 96.33 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.15 | gold quality |
| hair follicle | UBERON:0002073 | 92.93 | gold quality |
| cardiac atrium | UBERON:0002081 | 81.72 | gold quality |
| right atrium auricular region | UBERON:0006631 | 80.63 | gold quality |
| myocardium | UBERON:0002349 | 78.95 | gold quality |
| gingival epithelium | UBERON:0001949 | 78.10 | gold quality |
| gingiva | UBERON:0001828 | 77.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.23 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.64 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 70.23 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 67.47 | gold quality |
| vena cava | UBERON:0004087 | 65.80 | gold quality |
| heart | UBERON:0000948 | 65.70 | gold quality |
| heart left ventricle | UBERON:0002084 | 63.68 | gold quality |
| cardiac ventricle | UBERON:0002082 | 63.45 | gold quality |
| oral cavity | UBERON:0000167 | 63.25 | silver quality |
| squamous epithelium | UBERON:0006914 | 62.46 | silver quality |
| heart right ventricle | UBERON:0002080 | 58.04 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 57.63 | gold quality |
| cervix epithelium | UBERON:0004801 | 57.56 | silver quality |
| epithelium of esophagus | UBERON:0001976 | 57.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.88 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
104 targeting DSC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
Literature-anchored findings (GeneRIF, showing 11)
- The ultrastructural modifications of desmosomes during terminal differentiation of hair follicles are paralleled by the modulation of the synthesis of desmocollin 1. (PMID:15140019)
- in majority of patients with Netherton syndrome, Dsg1 & Dsc1 were reduced in living layers of epidermis; SCTE-like & SCCE-like activities were increased, suggesting these proteases participate in premature degradation of corneodesmosomal cadherins (PMID:16628198)
- Increased Dsc1 protein is associated with colorectal cancer (PMID:17088906)
- High expression of desmocollin 1 (DSC1) was observed in 41.6%, DSC2 in 58.0%, DSC3 in 61.4%, E-cadherin in 71.4%, CDX2 in 58.0%, PITX1 in 55.0%, CDK4 in 0.2%, TLE1 in 1.3%, Factor H in 42.5%, and MDM2 in 0.2% of colorectal carcinomas. (PMID:22438068)
- Low expression of DSC 1, 2, and 3 was observed in 55, 54, and 79 % of liver metastases. (PMID:23975055)
- Increased expression of DSC1 can promote the occurrence of head and neck squamous cell carcinoma (HNSCC) and is associated with tumor. The increased expression of DSC1 also indicates a poor prognosis of the patients with HNSCC. (PMID:27601166)
- DSC1 expression is significantly downregulated in human masticatory mucosa during wound healing (PMID:28005267)
- desmocollin-1 (DSC1) is validated as a protein connected with lymph node status of luminal A breast cancer, tumor grade, and Her-2 status and catechol-O-methyltransferase is successfully verified as a protein associated with lymph node metastasis of triple negative breast cancer. (PMID:31617665)
- CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129. (PMID:33637694)
- Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis. (PMID:34454985)
- Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide. (PMID:37620794)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dsc2l | ENSDARG00000039677 |
| mus_musculus | Dsc1 | ENSMUSG00000044322 |
| rattus_norvegicus | Dsc1 | ENSRNOG00000056258 |
Paralogs (6): DSG2 (ENSG00000046604), DSC2 (ENSG00000134755), DSG3 (ENSG00000134757), DSG1 (ENSG00000134760), DSC3 (ENSG00000134762), DSG4 (ENSG00000175065)
Protein
Protein identifiers
Desmocollin-1 — Q08554 (reviewed: Q08554)
Alternative names: Cadherin family member 1, Desmosomal glycoprotein 2/3
All UniProt accessions (2): Q08554, Q9HB00
UniProt curated annotations — full annotation on UniProt →
Function. A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion. Required for desmosome adhesion strength between the granular layers of the epidermis, as a result moderates epidermal proliferation and differentiation. Is therefore required to maintain postnatal epidermal barrier function and normal hair follicle morphology into adulthood.
Subunit / interactions. Binds to JUP/plakoglobin.
Subcellular location. Cell membrane. Cell junction. Desmosome.
Tissue specificity. Strongly expressed in epidermis, less in lymph node and tongue.
Domain organisation. Calcium may be bound by the cadherin-like repeats. Three calcium ions are usually bound at the interface of each cadherin domain and rigidify the connections, imparting a strong curvature to the full-length ectodomain.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q08554-1 | 1A, DG2 | yes |
| Q08554-2 | 1B, DG3 |
RefSeq proteins (2): NP_004939, NP_077739* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002126 | Cadherin-like_dom | Domain |
| IPR009122 | Desmosomal_cadherin | Family |
| IPR014868 | Cadherin_pro_dom | Domain |
| IPR015919 | Cadherin-like_sf | Homologous_superfamily |
| IPR020894 | Cadherin_CS | Conserved_site |
| IPR027397 | Catenin-bd_sf | Homologous_superfamily |
| IPR050971 | Cadherin-domain_protein | Family |
Pfam: PF00028, PF08758
UniProt features (74 total): strand 41, turn 11, domain 5, sequence variant 3, glycosylation site 2, splice variant 2, helix 2, topological domain 2, signal peptide 1, propeptide 1, modified residue 1, sequence conflict 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5IRY | X-RAY DIFFRACTION | 3.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q08554-F1 | 77.16 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 385
Glycosylation sites (2): 165, 546
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6798695 | Neutrophil degranulation |
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
MSigDB gene sets: 134 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_EPIDERMIS_MORPHOGENESIS, JAEGER_METASTASIS_DN, GOCC_SECRETORY_GRANULE, KAAB_HEART_ATRIUM_VS_VENTRICLE_UP, GOBP_CELLULAR_COMPONENT_MAINTENANCE, CEBPB_01, GOBP_CELL_CELL_ADHESION, GOBP_CELL_JUNCTION_ORGANIZATION, chr18q12, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
GO Biological Process (7): desmosome maintenance (GO:0002160), homophilic cell-cell adhesion (GO:0007156), hair follicle morphogenesis (GO:0031069), negative regulation of epithelial cell proliferation (GO:0050680), establishment of skin barrier (GO:0061436), cell-cell adhesion (GO:0098609), cell adhesion (GO:0007155)
GO Molecular Function (3): calcium ion binding (GO:0005509), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (9): cornified envelope (GO:0001533), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), desmosome (GO:0030057), extracellular exosome (GO:0070062), ficolin-1-rich granule membrane (GO:0101003), cell junction (GO:0030054), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell-cell junction | 2 |
| cellular anatomical structure | 2 |
| desmosome organization | 1 |
| cell-cell junction maintenance | 1 |
| cell-cell adhesion | 1 |
| hair follicle development | 1 |
| anatomical structure morphogenesis | 1 |
| hair cycle process | 1 |
| epidermis morphogenesis | 1 |
| negative regulation of cell population proliferation | 1 |
| epithelial cell proliferation | 1 |
| regulation of epithelial cell proliferation | 1 |
| skin epidermis development | 1 |
| cell adhesion | 1 |
| cellular process | 1 |
| metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| plasma membrane | 1 |
| membrane | 1 |
| cell periphery | 1 |
| extracellular vesicle | 1 |
| secretory granule membrane | 1 |
| tertiary granule | 1 |
| ficolin-1-rich granule | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
624 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DSC1 | CDSN | Q15517 | 995 |
| DSC1 | DSG1 | Q02413 | 987 |
| DSC1 | DSP | P15924 | 805 |
| DSC1 | KLK7 | P49862 | 647 |
| DSC1 | PPL | O60437 | 638 |
| DSC1 | JUP | P14923 | 636 |
| DSC1 | ING1 | Q9UK53 | 613 |
| DSC1 | DSG3 | P32926 | 600 |
| DSC1 | SPINK5 | Q9NQ38 | 595 |
| DSC1 | PKP1 | Q13835 | 586 |
| DSC1 | LORICRIN | P23490 | 577 |
| DSC1 | EVPL | Q92817 | 573 |
| DSC1 | FLG2 | Q5D862 | 571 |
| DSC1 | FLG | P20930 | 544 |
| DSC1 | DST | Q03001 | 540 |
IntAct
60 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PIK3CA | PIK3R1 | psi-mi:“MI:0914”(association) | 0.960 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| NCBP2 | KPNA3 | psi-mi:“MI:0914”(association) | 0.640 |
| MAPK7 | PFDN6 | psi-mi:“MI:0914”(association) | 0.640 |
| DSG1 | DSC1 | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| KSR2 | POLR3A | psi-mi:“MI:0914”(association) | 0.530 |
| CFTR | CNOT1 | psi-mi:“MI:0914”(association) | 0.480 |
| UBASH3B | BCR/ABL fusion | psi-mi:“MI:0914”(association) | 0.460 |
| DSC1 | DSG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GNAT3 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| BCAR1 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | NFKBIE | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | EIF3D | psi-mi:“MI:0914”(association) | 0.350 |
| METTL3 | TUBAL3 | psi-mi:“MI:0914”(association) | 0.350 |
| METTL14 | HMGB1P1 | psi-mi:“MI:0914”(association) | 0.350 |
| APBB1 | SSPOP | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| POC5 | CEP290 | psi-mi:“MI:0914”(association) | 0.350 |
| POC5 | DSC2 | psi-mi:“MI:0914”(association) | 0.350 |
| AP3B1 | psi-mi:“MI:0914”(association) | 0.350 | |
| SLX4 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| USP1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (147): DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A8M2BIB6, F1QSQ0, F8W3X3, H2EQR6, O35902, O54800, O55111, O93319, P32926, P33545, P55280, P55285, P55286, P55287, P55288, P55289, P55292, P55849, P55850, P70407, P70408, P79995, P97291, P97326, Q01107, Q02413, Q02487, Q08554, Q08DJ5, Q13634, Q14126, Q14574, Q28060, Q3SWX5, Q5DWV1, Q5RJH3, Q61495, Q68SP4, Q6W3B0, Q7TMD7
Diamond homologs: A0A8M2BIB6, B0KW95, B2KI42, B4USZ0, F1PAA9, H2EQR6, O18926, O35902, O55075, O55111, O88277, P08641, P09803, P10287, P10288, P12830, P15116, P19022, P19534, P19535, P20310, P22223, P24503, P30944, P32926, P33145, P33146, P33147, P33148, P33150, P33152, P33545, P39038, P55283, P55290, P55291, P55292, P55849, P55850, P79883
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 79 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cell-cell adhesion | 6 | 9.2× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
126 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 113 |
| Likely benign | 1 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 151144 | GRCh38/hg38 18q12.1(chr18:29365057-31236305)x1 | Pathogenic |
| 3242756 | NC_000018.9:g.(?28647981)(29178638_?)del | Pathogenic |
SpliceAI
2153 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:31130712:C:CC | acceptor_gain | 1.0000 |
| 18:31131592:A:AC | donor_gain | 1.0000 |
| 18:31131593:C:CC | donor_gain | 1.0000 |
| 18:31131667:C:CA | donor_gain | 1.0000 |
| 18:31132566:A:AC | donor_gain | 1.0000 |
| 18:31132566:A:AT | donor_loss | 1.0000 |
| 18:31132567:C:CC | donor_gain | 1.0000 |
| 18:31132575:T:TA | donor_gain | 1.0000 |
| 18:31132686:ATAC:A | acceptor_gain | 1.0000 |
| 18:31132687:TAC:T | acceptor_gain | 1.0000 |
| 18:31132687:TACC:T | acceptor_loss | 1.0000 |
| 18:31132690:C:CC | acceptor_gain | 1.0000 |
| 18:31132690:CTAAA:C | acceptor_loss | 1.0000 |
| 18:31132691:T:C | acceptor_loss | 1.0000 |
| 18:31134568:ATACC:A | donor_loss | 1.0000 |
| 18:31134570:A:AC | donor_gain | 1.0000 |
| 18:31134570:AC:A | donor_gain | 1.0000 |
| 18:31134570:ACC:A | donor_loss | 1.0000 |
| 18:31134570:ACCAT:A | donor_gain | 1.0000 |
| 18:31134571:C:A | donor_loss | 1.0000 |
| 18:31134571:C:CT | donor_gain | 1.0000 |
| 18:31134571:CC:C | donor_gain | 1.0000 |
| 18:31134571:CCAT:C | donor_gain | 1.0000 |
| 18:31134571:CCATC:C | donor_gain | 1.0000 |
| 18:31134574:T:TA | donor_gain | 1.0000 |
| 18:31134781:CCAA:C | acceptor_gain | 1.0000 |
| 18:31134782:CAA:C | acceptor_gain | 1.0000 |
| 18:31134782:CAAC:C | acceptor_gain | 1.0000 |
| 18:31134785:C:CC | acceptor_gain | 1.0000 |
| 18:31140045:AAG:A | donor_gain | 1.0000 |
AlphaMissense
5893 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:31145669:A:G | F294S | 0.999 |
| 18:31148562:A:C | N236K | 0.999 |
| 18:31148562:A:T | N236K | 0.999 |
| 18:31134591:C:A | W619C | 0.998 |
| 18:31134591:C:G | W619C | 0.998 |
| 18:31140183:A:T | V460D | 0.998 |
| 18:31140189:A:T | V458D | 0.998 |
| 18:31143757:C:G | R325P | 0.998 |
| 18:31148551:G:T | P240Q | 0.998 |
| 18:31148560:T:G | D237A | 0.998 |
| 18:31148570:C:G | D234H | 0.998 |
| 18:31134058:T:G | D650A | 0.997 |
| 18:31134593:A:G | W619R | 0.997 |
| 18:31134593:A:T | W619R | 0.997 |
| 18:31143687:A:C | N348K | 0.997 |
| 18:31143687:A:T | N348K | 0.997 |
| 18:31143706:A:T | I342N | 0.997 |
| 18:31143754:T:G | D326A | 0.997 |
| 18:31143755:C:G | D326H | 0.997 |
| 18:31143772:A:G | L320S | 0.997 |
| 18:31145642:A:T | I303N | 0.997 |
| 18:31145709:A:C | Y281D | 0.997 |
| 18:31145741:T:G | D270A | 0.997 |
| 18:31145753:G:T | A266D | 0.997 |
| 18:31148560:T:A | D237V | 0.997 |
| 18:31148561:C:G | D237H | 0.997 |
| 18:31148563:T:A | N236I | 0.997 |
| 18:31148568:A:C | D234E | 0.997 |
| 18:31148568:A:T | D234E | 0.997 |
| 18:31148569:T:A | D234V | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000115610 (18:31137496 C>T), RS1000116086 (18:31163258 T>A,C), RS1000462154 (18:31148341 C>T), RS1000609063 (18:31141067 G>A), RS1000711346 (18:31161966 T>C), RS1000864896 (18:31152613 G>A,T), RS1001139724 (18:31149637 T>C), RS1001147937 (18:31158050 C>T), RS1001200864 (18:31147153 A>T), RS1001318004 (18:31158249 A>G), RS1001385196 (18:31159017 C>T), RS1001441228 (18:31130977 T>C), RS1001487799 (18:31149335 A>G), RS1001515879 (18:31153109 T>C), RS1001747353 (18:31143012 T>C)
Disease associations
OMIM: gene MIM:125643 | disease phenotypes: MIM:610476, MIM:105210
GenCC curated gene-disease
Mondo (2): arrhythmogenic right ventricular dysplasia 11 (MONDO:0012506), amyloidosis, hereditary systemic 1 (MONDO:0971004)
Orphanet (2): ATTRV30M amyloidosis (Orphanet:85447), ATTRV122I amyloidosis (Orphanet:85451)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C566471 | Arrhythmogenic Right Ventricular Dysplasia, Familial, 11 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5724910 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 1,538 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL1232461 | MOLIBRESIB | 2 | 1,538 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.37 | IC50 | 4310 | nM | MOLIBRESIB |
PubChem BioAssay actives
1 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide | 2179016: Inhibition of DSC1 (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | ic50 | 4.3100 | uM |
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 3 |
| sodium arsenite | decreases expression, increases abundance, decreases reaction | 2 |
| Antimony Potassium Tartrate | decreases expression, increases abundance, decreases reaction | 2 |
| 4-oxoretinoic acid | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| deoxynivalenol | increases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| terbufos | increases methylation | 1 |
| arsenite | decreases expression, increases abundance, decreases reaction | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| antimonite | decreases expression, increases abundance, decreases reaction | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| U 0126 | decreases expression, decreases reaction, increases abundance, increases reaction | 1 |
| rofecoxib | affects expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one | decreases expression, decreases reaction, increases reaction | 1 |
| Alitretinoin | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Aerosols | decreases expression | 1 |
| Arsenic | increases abundance, decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Ibuprofen | affects expression | 1 |
| Parathion | increases methylation | 1 |
ChEMBL screening assays
6 unique, capped per target: 6 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5697746 | Binding | Inhibition of DSC1 (unknown origin) assessed as fold change at 10 uM incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. — Nature |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): amyloidosis, hereditary systemic 1, arrhythmogenic right ventricular dysplasia 11